Urovant Sciences, Inc.

Jeraygo (aprocitentan), Idorsia ’s first-of-its-kind treatment for resistant hypertension, is among the latest batch of new drugs that the European Medicines Agency today announced should be approved

The European Medicines Agency is this week deciding whether to recommend pan-EU marketing approval for seven new products, including Idorsia ’s aprocitentan, which last month became the first oral an

Sumitomo Pharma Co., Ltd. has decided to cut another 400 employees at its US subsidiary Sumitomo Pharma America, Inc. (SPMA) after already reducing headcount there by 500 in an earlier reorganization

The European Medicines Agency has started reviewing 15 new products for potential pan-EU marketing approval, including two hemophilia treatments – fidanacogene elaparvovec, Pfizer / Spark Therapeutic